Finanza

Notizie Discussioni Tecnici Previsione Stagionalità

Utile operativo su Lexeo Therapeutics, Inc..

Dati annuali

2021

2022

2023

2024

TTM

‪‪−120,00 M‬‬

‪‪−90,00 M‬‬

‪‪−60,00 M‬‬

‪‪−30,00 M‬‬

‪0,00‬

Periodo

Valore

Variazione

Variazione %

TTM

‪‪−105,77 M‬‬

‪0,00‬

‪0,00‬%

2024

‪‪−105,77 M‬‬

‪‪−37,25 M‬‬

‪−54,37‬%

2023

‪‪−68,51 M‬‬

‪‪−8,00 M‬‬

‪−13,23‬%

2022

‪‪−60,51 M‬‬

‪‪−9,87 M‬‬

‪−19,50‬%

2021

‪‪−50,64 M‬‬

‪‪−46,05 M‬‬

‪‪−1,00 K‬‬%

Dati trimestrali

Q2 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪‪−32,00 M‬‬

‪‪−24,00 M‬‬

‪‪−16,00 M‬‬

‪‪−8,00 M‬‬

‪0,00‬

Periodo

Valore

Variazione

Variazione %

Q4 '24

‪‪−27,38 M‬‬

+‪‪4,16 M‬‬

+‪13,19‬%

Q3 '24

‪‪−31,54 M‬‬

‪‪−7,99 M‬‬

‪−33,94‬%

Q2 '24

‪‪−23,55 M‬‬

‪‪−259,00 K‬‬

‪−1,11‬%

Q1 '24

‪‪−23,29 M‬‬

‪‪−8,32 M‬‬

‪−55,54‬%

Q4 '23

‪‪−14,97 M‬‬

+‪‪5,30 M‬‬

+‪26,14‬%

Q3 '23

‪‪−20,27 M‬‬

‪‪−6,30 M‬‬

‪−45,07‬%

Q2 '23

‪‪−13,97 M‬‬

+‪‪5,32 M‬‬

+‪27,55‬%

Q1 '23

‪‪−19,29 M‬‬

‪‪−3,98 M‬‬

‪−25,99‬%

Q2 '22